查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513980

全球生物技术设备市场

Biotechnology Instrumentation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 246 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年，全球生物技术设备市场预计将达到749亿美元

2023年全球生物技术设备市场预计为514亿美元，预计到2030年将达到749亿美元，2023年至2030年复合年增长率为5.5%。免疫检测系统是本报告分析的细分市场之一，预计复合年增长率为 4.5%，到分析期结束时将达到 261 亿美元。分析期间，DNA定序系统领域的复合年增长率预计为 7.8%。

美国市场预计137亿美元，中国预计复合年增长率5.2%

2023年美国生技设备市场预计将达137亿美元。中国作为世界第二大经济体，预计2030年市场规模将达119亿美元，2023-2030年分析期间复合年增长率为5.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.8% 和 4.7%。在欧洲，德国的复合年增长率预计为 4.3%。

全球生物技术设备市场—主要趋势与驱动因素总结

生物技术产业处于科学进步的最前沿，正在应对从疾病治疗到永续农业的全球挑战，推动了对先进生物技术设备的需求。在研发投资的推动下，该领域的进步正在彻底改变遗传、蛋白质和细胞分析，对医疗保健、农业和环境科学产生深远影响。主要市场驱动因素包括基因组学和蛋白​​质组学的进步、监管合规性以及生物製药的扩张。

随着产业的发展，生物技术设备将继续推动医疗诊断和环境生物技术的创新，呈现自动化、小型化、与人工智慧技术融合等趋势。基因组学和蛋白​​质组学的进步将需要次世代定序仪、质谱仪和层析法系统，而监管标准将增加对精密仪器的需求。生物製药的成长推动了对生物製造设备的需求，技术整合提高了效率和决策流程。

未来，人工智慧整合和永续性实践将再形成生物技术设备，支援高通量筛检，并扩大就地检验能力。小型化可以灵活使用，人工智慧和机器学习提高了资料分析的准确性。生物技术设备不断发展，以满足科学研究和医疗保健的多样化需求，重点是永续性和就地检验的扩展。

受访企业范例（共147家）

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • GE HealthCare（UK）
  • Gilson Inc.
  • Harvard Bioscience Inc.
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Shimadzu Corp.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Waters Corp.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP-3504

Global Biotechnology Instrumentation Market to Reach US$74.9 Billion by 2030

The global market for Biotechnology Instrumentation estimated at US$51.4 Billion in the year 2023, is expected to reach US$74.9 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Immunoassay Systems, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$26.1 Billion by the end of the analysis period. Growth in the DNA Sequencing Systems segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Billion While China is Forecast to Grow at 5.2% CAGR

The Biotechnology Instrumentation market in the U.S. is estimated at US$13.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.9 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Biotechnology Instrumentation Market - Key Trends and Drivers Summarized

The biotechnology industry, at the forefront of scientific advancement, addresses global challenges from disease treatment to sustainable agriculture, spurring demand for sophisticated biotechnology instrumentation. Advancements in this field, driven by investments in R&D, revolutionize genetic, protein, and cellular analyses, impacting healthcare, agriculture, and environmental sciences profoundly. Key market growth drivers include advancements in genomics and proteomics, regulatory compliance, and the expansion of biopharmaceuticals.

As the industry evolves, biotechnology instruments will continue to drive innovation in medical diagnostics and environmental biotechnology, with trends leaning towards automation, miniaturization, and integration with AI technologies. Genomics and proteomics advancements necessitate next-generation sequencing devices, mass spectrometers, and chromatography systems, while regulatory standards drive demand for precise instrumentation. The growth of biopharmaceuticals fuels demand for bio-manufacturing instruments, and technological integration enhances efficiency and decision-making processes.

Looking ahead, AI integration and sustainability practices will reshape biotechnology instrumentation, supporting high-throughput screening and expanding point-of-care testing capabilities. Miniaturization allows for flexible use, while AI and machine learning improve data analysis accuracy. With a focus on sustainability and the expansion of point-of-care testing, biotechnology instrumentation continues to evolve, meeting the diverse needs of scientific research and healthcare.

Select Competitors (Total 147 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • GE HealthCare (UK)
  • Gilson Inc.
  • Harvard Bioscience Inc.
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Shimadzu Corp.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Waters Corp.)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biotechnology Instrumentation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Genomic Sequencing Technologies Propel Market Growth
    • Rising Demand for Personalized Medicine Strengthens Business Case for Biotechnology Instruments
    • Growing Application of CRISPR Technology Generates Demand for Advanced Instrumentation
    • Development of Portable and Miniaturized Instruments Accelerates Market Expansion
    • Integration of Artificial Intelligence in Biotechnology Instrumentation Enhances Efficiency
    • Innovations in Proteomics and Metabolomics Throw the Spotlight on Specialized Instruments
    • Expansion of Pharmaceutical and Biopharmaceutical Industries Spurs Market Growth
    • Focus on Drug Discovery and Development Sustains Growth in Biotechnology Instrumentation Market
    • Rising Incidence of Chronic Diseases Generates Demand for Diagnostic Instruments
    • Emphasis on High-Throughput Screening Expands Addressable Market Opportunity
    • Growth in Synthetic Biology Spurs Demand for Custom Instruments
    • Adoption of Cloud-Based Solutions Drives Adoption of Digital Biotechnology Instruments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biotechnology Instrumentation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for DNA Sequencing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for MicroArrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Liquid Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Laboratory Automation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Electrophoresis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Product Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • JAPAN
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • CHINA
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • EUROPE
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • FRANCE
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 47: France Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: France Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: France 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • GERMANY
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Germany Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Germany 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 53: Italy Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Italy Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Italy 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: UK 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Rest of Europe 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Asia-Pacific 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 65: Rest of World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of World Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of World 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030

IV. COMPETITION